FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019595 [Registered on: 10/06/2019] Trial Registered Prospectively
Last Modified On: 06/06/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Shalmalikantaka Lepa and Raktachandanadi Lepa along with Kaishor Guggulu on Yauvanpidika 
Scientific Title of Study   A comparative study on Yauvanpidika(Acne Vulgaris) with management by Shalmalikantaka Lepa and Raktachandanadi Lepa along with Kaishor Guggulu  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Binal D Gondalia 
Designation  PG Scholar 
Affiliation  Govt Akhandanand Ayurved College 
Address  Room No 9 Kayachikitsa Department Govt Akhandanand Ayurved College Bhadra Ahmedabad

Ahmadabad
GUJARAT
380001
India 
Phone  9925027291  
Fax    
Email  binalgondalia2010@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mustak N Shaikh 
Designation  Associate Professor 
Affiliation  Govt Akhandanand Ayurved College 
Address  Room No 9 Kayachikitsa Department Govt Akhandanand Ayurved College Bhadra Ahmedabad

Ahmadabad
GUJARAT
380001
India 
Phone  9824440708  
Fax    
Email  shaikhmustak542@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Binal D Gondalia 
Designation  PG Scholar 
Affiliation  Govt Akhandanand Ayurved College 
Address  Room No 9 Kayachikitsa Department Govt Akhandanand Ayurved College Bhadra Ahmedabad

Ahmadabad
GUJARAT
380001
India 
Phone  9925027291  
Fax    
Email  binalgondalia2010@gmail.com  
 
Source of Monetary or Material Support  
None 
 
Primary Sponsor  
Name  Govt Akhandanand Ayurved College 
Address  Govt Akhandanand Ayurved College Bhadra Ahmedabad 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Binal D Gondalia  Govt Akhandanand Ayurved College Ahmedabad   Room No 9 Kayachikitsa Department Govt Akhandanand Ayurved College Bhadra Ahmedabad
Ahmadabad
GUJARAT 
9925027291

binalgondalia2010@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L700||Acne vulgaris,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Kaishor Guggulu and Raktachandanadi Lepa  15 patients wil be taken in group B and Kaishor Guggulu will be prepared as described in Sharangdhara Samhita Guggulu Kalpana and patients will be treated in following dose and duration Dose 3 tablets thrice a day each tablet is 500 mg with Khadir sidhha jala 20 ml for 4 weeks Raktachandanadi Lepa will be prepared as described in Sharangdhara Samhita Dose 20 gm per day apply with milk Administration local application on affected area Duration 4 weeks Single sitting duration Lepa will be remove before it becomes 70% dry  
Intervention  Kaishor Guggulu and Shalmalikantaka Lepa   15 patients will be taken in group A and Kaishor Guggulu will be prepared as described in Sharangdhara Samhita Guggulu Kalpana and will be treated in following dose and duration Dose 3 tablets thrice a day each tablet is 500 mg with Khadir sidhha jala 20 ml for 4 weeks Shalmalikantaka Lepa will be prepared as described in Sharangdhara Samhita Dose 20 gm per day apply with milk Administration local application on affected area Duration 4 weeks single sitting duration Lepa will be remove before it becomes 70% dry 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  32.00 Year(s)
Gender  Both 
Details  Classical sign and symptoms of Yauvanpidika like Paka Strava Kandu Vedana and Daha  
 
ExclusionCriteria 
Details  Any pidika due to systemic disease like Prameha pidika Masurika
cancer AIDS STD TB and other disorder which lead to fatal condition for patients
Female with pathological involvement sex hormones like primary infertility Hormone replacement therapy Taking OCP will be excluded 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Result will be assessed on the basis of sign and symptoms Yauvanpidika  4 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
None  None 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NONE 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   To study the efficacy of Shalmalikantaka Lepa and Raktachandanadi Lepa along with Kaishor Guggulu in the management of Yauvanpidika 
This study is Randomized Controlled Open Lable Parallel Group Trial
 
Close